COMMUNIQUÉS West-GlobeNewswire

VBL Therapeutics to Report Fiscal 2017 Results on March 15

09/03/2018 - 14:00

TEL AVIV, Israel, March 09, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

09/03/2018 - 13:30

DUBLIN, Ireland, March 09, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq AVDL), “Avadel” or “the Company,” today announced that management will present at two upcoming investor conferences: The 30 th [...]

Projecting a Per Share Price Target of $1.25, PotNetwork Holding Inc. Highlighted as “Strong Speculative Buy” in Research Initiated by Harbinger Research, LLC

09/03/2018 - 13:27

FT LAUDERDALE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holding, Inc. (OTC Pink:POTN ) (“Company”) is pleased to announce today that PotNetwork the Company and Diamond CBD have been the [...]

Orphazyme to Present at Cowen & Co. 38th Annual Health Care Conference

09/03/2018 - 13:23

Orphazyme A/S Investor news No. 04/2018 Copenhagen, March 9, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders [...]

Sonoma Pharmaceuticals to Present at Roth Capital Partners 30th Annual Growth Stock Conference on March 13, 2018

09/03/2018 - 13:05

PETALUMA, Calif., March 09, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA, Warrants – SNOAW) today announced that Jim Schutz, Sonoma CEO, will be a featured presenter at the Roth Capital Partners [...]

Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease

09/03/2018 - 13:02

Robust and durable improvements in patients' motor function achieved with substantial reductions in use of daily oral levodopa and other Parkinson’s disease medications; one-time administrations of VY-AADC well- [...]

ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

09/03/2018 - 13:01

Pipeline Achievements in 2017 Included Progress with Three Phase 3 and Two Phase 2 Clinical Trials -Key 2018 Clinical Milestones Anticipated for All Three Development Compounds Lead Compound OBE2109 Endometriosis Phase [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

09/03/2018 - 13:01

FIT Biotech Oy Company release March 9, 2018 at 2.00 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

MacroGenics to Present at Cowen Health Care Conference

09/03/2018 - 13:00

Rockville, MD, March 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2017 Results on March 15, 2018

09/03/2018 - 13:00

FREMONT, Calif., March 09, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:ST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]

Trillium Therapeutics Reports Annual 2017 Financial and Operating Results

09/03/2018 - 13:00

Presented evidence of clinical activity and good tolerability from both TTI-621 trials at ASH Received FDA clearance to proceed with second clinical CD47 program, TTI-622 Cash and marketable securities of $81.8 million [...]

ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights

09/03/2018 - 13:00

-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% of patient enrollment target as European Medicine Agency continues review process of Conditional Marketing Authorization application [...]

Anavex Life Sciences to Present at the 30th Annual ROTH Conference

09/03/2018 - 13:00

NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

R1 RCM Reports Fourth Quarter and Full Year 2017 Results

09/03/2018 - 13:00

CHICAGO, March 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]

Solon Eiendom ASA : Extraordinary general meeting

09/03/2018 - 11:13

Solon Eiendom ASA (OSE: SOLON), held an extraordinary general meeting at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018. All proposals were resolved as presented in the notice convening the [...]

Fertin Pharma A/S is awarded another issued patent on one-layered compressed nicotine gum

09/03/2018 - 08:44

VEJLE, Denmark, March 09, 2018 (GLOBE NEWSWIRE) -- The market leading nicotine gum manufacturer, Fertin Pharma A/S, adds another milestone in the protection of compressed nicotine gum. While Fertin Pharma A/S has [...]

Proposed merger between Medical Prognosis Institute and Oncology Venture

09/03/2018 - 08:01

Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) and Oncology Venture Sweden AB (publ) ("Oncology Venture" or "OV") (AktieTorget: OV) today jointly announce that their [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

09/03/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 9 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock

09/03/2018 - 04:00

SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]